Bicycle Therapeutics Plc financial data

Symbol
BCYC on Nasdaq
Industry
Pharmaceutical Preparations
Location
Blocks A & B, Portway Building, Granta Park, Great Abington, Cambridge, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
BICYCLE THERAPEUTICS Ltd (to 5/24/2019)
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.25K % +76.7%
Debt-to-equity 31.5 % -53.8%
Return On Equity -27.4 % +51.3%
Return On Assets -20.8 % +37.8%
Operating Margin -532 % +21.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30M shares +1.33%
Common Stock, Shares, Outstanding 69M shares +62.8%
Entity Public Float 767M USD +56.7%
Common Stock, Value, Issued 890K USD +61.8%
Weighted Average Number of Shares Outstanding, Basic 69M shares +74.3%
Weighted Average Number of Shares Outstanding, Diluted 69M shares +74.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 36.9M USD +48.6%
Research and Development Expense 168M USD +23%
General and Administrative Expense 65.5M USD +16.4%
Operating Income (Loss) -196M USD -17%
Nonoperating Income (Expense) 26.8M USD +278%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -170M USD -5.48%
Income Tax Expense (Benefit) -3.36M USD -569%
Net Income (Loss) Attributable to Parent -166M USD -2.93%
Earnings Per Share, Basic -3.24 USD/shares +34.9%
Earnings Per Share, Diluted -3.24 USD/shares +34.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 891M USD +55.7%
Accounts Receivable, after Allowance for Credit Loss, Current 233K USD -99.5%
Assets, Current 966M USD +60.2%
Property, Plant and Equipment, Net 11.5M USD -26.1%
Operating Lease, Right-of-Use Asset 9.09M USD -37.7%
Other Assets, Noncurrent 9.94M USD +82.4%
Assets 997M USD +56.1%
Accounts Payable, Current 5.71M USD -32.7%
Employee-related Liabilities, Current 13M USD +33%
Accrued Liabilities, Current 39.3M USD +15.4%
Liabilities, Current 56.4M USD -19.1%
Operating Lease, Liability, Noncurrent 5.53M USD -46.9%
Other Liabilities, Noncurrent 5.96M USD +38.2%
Liabilities 166M USD -25.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.19M USD -210%
Retained Earnings (Accumulated Deficit) -629M USD -35.9%
Stockholders' Equity Attributable to Parent 831M USD +99.8%
Liabilities and Equity 997M USD +56.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -70.9M USD -52.7%
Net Cash Provided by (Used in) Financing Activities 1.87M USD -31.2%
Net Cash Provided by (Used in) Investing Activities -12K USD +99.4%
Common Stock, Shares Authorized 156M shares +161%
Common Stock, Shares, Issued 69M shares +62.8%
Common Stock, Par or Stated Value Per Share 0.01 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -69.4M USD -53.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 891M USD +55.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 686K USD +1.03%
Deferred Tax Assets, Valuation Allowance 80.3M USD +49.4%
Deferred Tax Assets, Gross 88.6M USD +33.5%
Operating Lease, Liability 10.9M USD -27.7%
Depreciation 6.6M USD +11.9%
Payments to Acquire Property, Plant, and Equipment 12K USD -99.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -172M USD -8.27%
Lessee, Operating Lease, Liability, to be Paid 17.1M USD +358%
Property, Plant and Equipment, Gross 28.2M USD +0.64%
Operating Lease, Liability, Current 5.37M USD +15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.46M USD -39.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.01M USD +6.21%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -767K USD +63.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 858K USD -52.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 821K USD -74.9%
Deferred Tax Assets, Operating Loss Carryforwards 66.6M USD +46.4%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 821K USD 0%
Operating Lease, Payments 1.44M USD +6.22%
Additional Paid in Capital 1.46B USD +67.1%
Depreciation, Depletion and Amortization 1.66M USD +6.49%
Share-based Payment Arrangement, Expense 35.6M USD +17.7%
Interest Expense 3.28M USD -1.74%